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response in Leishmania donovani
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Abstract
Background: Protozoan parasites of the genus Leishmania are responsible for leishmaniasis, a neglected tropical
disease affecting millions worldwide. Visceral leishmaniasis (VL), caused by Leishmania donovani, is the most severe
form of leishmaniasis with high rates of mortality if left untreated. Current treatments include pentavalent antimonials
and amphotericin B. However, high toxicity and emergence of resistance hinder the success of these options.
Miltefosine (HePC) is the first oral treatment available for leishmaniasis. While treatment with HePC has proven
effective, higher tolerance to the drug has been observed, and experimental resistance is easily developed in an in vitro
environment. Several studies, including ours, have revealed that HePC resistance has a multi-factorial origin and this work
aims to shed light on this complex mechanism.
Methods: 2D-DIGE quantitative proteomics comparing the soluble proteomes of sensitive and HePC resistant
L. donovani lines identified a protein of interest tentatively involved in drug resistance. To test this link, we
employed a gain-of-function approach followed by mutagenesis analysis. Functional studies were complemented with
flow cytometry to measure HePC incorporation and cell death.
Results: We identified a mitochondrial HSP70 (HSPA9B) downregulated in HePC-resistant L. donovani promastigotes.
The overexpression of HSPA9B in WT lines confers an increased sensitivity to HePC, regardless of whether
the expression is ectopic or integrative. Moreover, the increased sensitivity to HePC is specific to the HSPA9B
overexpression since dominant negative mutant lines were able to restore HePC susceptibility to WT values. Interestingly,
the augmented susceptibility to HePC did not correlate with an increased HePC uptake. Leishmania donovani
promastigotes overexpressing HSPA9B were subjected to different environmental stimuli. Our data suggest
that HSPA9B is capable of protecting cells from stressful conditions such as low pH and high temperature.
This phenotype was further corroborated in axenic amastigotes overexpressing HSPA9B.
Conclusions: The results from this study provide evidence to support the involvement of a mitochondrial
HSP70 (HSPA9B) in experimental HePC resistance, a mechanism that is not yet fully understood, and reveal
potential fundamental roles of HSPA9B in the biology of Leishmania. Overall, our findings are relevant for
current and future antileishmanial chemotherapy strategies.
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Background
The intracellular protozoan parasites belonging to the
genus Leishmania are the causative agents of leishman-
iasis, a neglected tropical disease with several clinical
manifestations. Species of the Leishmania donovani
complex are responsible for the most severe form of the
infection, visceral leishmaniasis (VL), also known as
kala-azar [1]. VL is clinically characterized by fever, loss
of appetite, fatigue, hepatosplenomegaly and splenomeg-
aly. If VL is not treated the fatality rate can be as high as
100% in developing countries. As much as 90% of VL
cases take place in Bangladesh, Brazil, Ethiopia, India,
South Sudan and Sudan and approximately 500,000 new
cases are reported each year [2]. Leishmania spp. have a
digenetic life-cycle including both extracellular promas-
tigote and obligate intracellular amastigote forms. Extra-
cellular flagellated promastigotes reside in the midgut of
the phlebotomine sand fly vector. Following infection in
the mammalian host, promastigotes are engulfed by
macrophages where they differentiate into non-motile
amastigotes in the phagolysosome. This differentiation is
triggered by environmental cues, mainly pH and
temperature [3].
For the last 75 years, control of the illness has largely
relied on the use of pentavalent antimonials, but resist-
ance emergence and high toxicity have been the driving
forces to seek novel and more effective treatments. For
almost 15 years, the alkyl-lyso-phospholipid analogue
hexadecyl-phosphatidylcholine has been used as the first
and only oral drug to treat VL. This compound, com-
mercially known as miltefosine (HePC), was initially in-
troduced as an anti-neoplastic treatment in the 1980s,
however an alternative use was discovered by Croft and
collaborators in 1987 when they explored its effect
against L. donovani amastigotes in cultured mouse peri-
toneal macrophages [4]. Since 1999, the use of HePC as
an oral treatment has been evaluated in several clinical
trials, showing 90–100% cure rate and up to 20% relapse
rates [5]. While evidence of clinical HePC resistance is
limited, its long half-life and low therapeutic window
favour the resistance emergence.
It has been previously shown that the most common
experimental mechanism of HePC resistance is associ-
ated with reduced drug accumulation. The presence of
loss of function mutations in the HePC transporter
subunits, MT and/or Ros3, as well as an increased efflux
of the drug as a consequence of the overexpression of
ABC transporters may lead to reduce HePC susceptibil-
ity [6–8]. After a comprehensive study of the phenotyp-
ical traits of clonal lines of HePC resistant L. donovani
promastigotes, which included whole genome and RNA
sequencing, we concluded that defects in drug transloca-
tion machinery cannot thoroughly explain the multifac-
torial mechanism of HePC resistance. Amino acid and
folate metabolism, changes in membrane composition
and stress-induced responses are likely involved in the
resistant phenotype, as revealed by the differential abun-
dance of these transcripts [9].
To obtain a better understanding of the complex
mechanism associated with HePC resistance, we further
complemented our studies with a proteomic approach
and compared the protein expression profiles of in vitro
HePC resistant lines to wild type L. donovani promasti-
gotes. Whole protein extracts from L. donovani HePC
resistant promastigotes were analyzed via 2D-DIGE and
a mitochondrial isoform of HSP70 (LinJ.30.2480), re-
ferred to as HSPA9B [10], was identified. Heat-shock
proteins (HSP) are highly conserved and constitutively
expressed molecules whose chief functions are to facili-
tate protein synthesis and folding. Additionally, they
contribute to protein assembly, intracellular trafficking,
turn-over and regulation [11]. Originally discovered as
gene products whose overexpression was associated to a
heat-shock response, it is now widely known that their
synthesis can be induced by cellular stress other than
heat, such as exposure to cold, UV light, starvation, hyp-
oxia, exposure to toxins, tissue remodeling, etc. These
molecules are traditionally classified base on their mo-
lecular mass [12]. The 70-kDa family of HSPs are repre-
sented by several homologs that differ in their
subcellular localization (i.e. cytoplasm, ER, mitochondria
and chloroplasts). In higher eukaryotes, it is possible to
find both constitutively expressed (HSC70) and stress in-
ducible isoforms (HSP70). Mitochondrial HSP70s can be
localized at the inner mitochondrial membrane or the
mitochondrial matrix and phylogenetic studies indicated
that this subtype is more closely related to the bacterial
DnaK [13]. Similar to their cytosolic counterpart, mito-
chondrial HSP70s display housekeeping functions and
are responsible for protein folding and assembly, refold-
ing, organelle trafficking and quality control [11]. All of
these activities require HSP70 proteins to recognize and
interact with hydrophobic peptide segments in an ATP-
dependent mechanism. The HSP70 family is highly con-
served and each protein contains an N-terminal ATPase
domain, a substrate binding domain comprising of both
a 25 kDa β sheet subdomain and a 10 kDa helical subdo-
main and lastly a C-terminal domain rich in alpha hel-
ical structure [11, 14]. Several biochemical studies
carried out in both bacteria and yeast have demonstrated
the essentiality of specific amino acids localized at the
ATPase and substrate binding domains for proper pro-
tein functioning [15–18]. HSP70 molecules have been
widely studied in trypanosomes, as temperature shifts
are part of the life-cycle of these organisms. It has been
shown that a mitochondrial member of the HSP70 fam-
ily in Trypanosoma cruzi is associated with kinetoplast
DNA [19, 20] and in dyskinetoplastic Trypanosoma
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brucei mutants, the protein is distributed throughout the
mitochondria [21]. Studies carried out in Leishmania
major demonstrated that a mitochondrial HSP70 iso-
form is constitutively expressed and localizes to the
mitochondria in all the parasite life stages [22]. The ex-
pression of a family of HSP70 genes in L. donovani was
similarly detected in all parasite life stages but in con-
trast to what it was observed in L. major, T. cruzi and T.
brucei, the expression level was not significantly heat
inducible [23].
In this work, we employ quantitative proteomics and a
gain-of-function approach to link HSPA9B protein to
HePC susceptibility. Interestingly, this phenotype is not
related to a faulty drug accumulation. Furthermore, we
find transgenic parasites to be more resistant to several
stress conditions, suggesting that HSPA9B contributes to
the parasite stress response.
Methods
Parasite culture
Leishmania donovani wild type strain 1S2D (MHOM/
SD/62/1S-CL2D), LdR10.1 and LdR30.1 clones [9] and
transgenic lines were cultured in M199 supplemented
with 10% FCS at 26 °C and pH 7.4 and axenic amasti-
gotes were differentiated as described previously [24].
HePC resistant parasites were continuously maintained
in the presence of 10 and 30 μM of HePC.
Molecular constructs and parasite transfection
In order to generate a recombinant HSPA9B protein, a
2 kb region containing HSPA9B (LinJ.30.2480) was amp-
lified from genomic DNA of L. donovani using the
primers 5′-GCA GAT CTA TGT TCG CTC GTC GTG
TGT GC-3′(BglII) and 5′-CGC GGT ACC CTT CTT
TTC CTC GCT GTT CT-3′(KpnI) and LongAmp high-
fidelity Taq-DNA polymerase (New England Biolabs,
Ipswich, USA) following the manufacturer’s recommen-
dation. The product was cloned into pGEM-T (Promega,
Fitchburg, USA) to create pGEM-T-HSPA9B. C-terminal
HSPA9B-mCherry fusion was obtained by inserting the
2 kb HSPA9B construct from pGEM-T into the respect-
ive site of pLEXSY-mCherry (HYG). The HSPA9B-
mCherry-pLEXSY construct was then transformed in
DH5α E. coli cells (New England Biolabs, Ipswich, USA).
N-terminal GFP-HSPA9B fusions were obtained by
inserting the 2 kb HSPA9B construct from pGEM-T into
pXG-GFP + 2′ [25]. Episomal (GFP-HSPA9B) and inte-
grative (HSPA9B-mCherry) transgenic parasites were
established by electroporation of L. donovani promasti-
gotes from logarithmic culture (density < 5 × 106/ml)
with 75 μg of circular DNA or 7.5 μg of SwaI linearized
DNA, respectively. Transfected cells were grown in
media containing 50 μg/ml HygromycinB (HYGB) and
further selected in 100 μg/ml HYGB or selected in
media containing 20 μg/ml G418. Mock transfection
controls were performed in an identical manner with the
respective empty vector. Generation of mutants for
HSPA9B was accomplished with the QuikChange® II XL
Site-Directed Mutagenesis kit (Stratagene, La Jolla,
USA). Glycine 220 and 221 were mutated to Aspartic
acid (G220D, G221D) and Phenylalanine 436 to Valine
(F436V) to generate HSPA9B-mCherry (GxD, GxD) and
HSPA9B-mCherry (GxD, GxD, FxV) mutants. Construc-
tions were episomally introduced as described above.
Growth curves and drug susceptibility assays
The growth rate of transfected parasite cultures was mea-
sured and compared to mock controls. Parasites were
seeded in triplicate at an initial concentration of 5 × 105
parasites/ml and promastigote density was assessed daily
by direct microscopic counting until the parasites reached
stationary phase. The leishmanicidal effect of HePC
(Sigma-Aldrich, St. Louis, USA), pentamidine isethionate
(Sigma-Aldrich, St. Louis, USA), amphotericin B (Sigma-
Aldrich, St. Louis, USA), potassium antimony (III) tartrate
hydrate (Sigma-Aldrich, St. Louis, USA) and paromomy-
cin sulfate salt (Sigma-Aldrich, St. Louis, USA) was also
evaluated. For this purpose, culture viability was measured
by using the resazurin-based method CellTiter-Blue
(Promega, Fitchburg, USA) as described previously [26].
Briefly, 200 μl 1 × 106 parasites/ml were seeded in each
well of a 96-well plate and incubated in the presence of in-
creasing drug concentrations for 48 h at 26 °C along with
appropriate solvent controls. 100 μl of each well was
transferred to a new plate, 20 μl of the reagent was added
and after 4 h at 37 °C fluorescence was measured (555 nm
λexc/580 nm λem) using a Typhoon FLA 9500 laser scan-
ner (GE Healthcare, Chicago, USA) and analyzed with
ImageQuant TL software (GE Healthcare, Chicago, USA).
Each assay was performed in triplicate. The EC50 values
were calculated by non-linear regression analysis using
SigmaPlot for Windows version 11.0.
Determination of HePC accumulation
Parasites from a logarithmic-phase culture were washed
with HPMI buffer [20 mM HEPES, 132 mM NaCl,
3.5 mM, KCl, 0.5 mM MgCl2, 1 mM CaCl2, (pH 7.4)]
and pre-incubated in the same buffer for 30 min at 26 °C
with 1 mM phenylmethylsulfonyl fluoride (to block lipid
catabolism) and then labeled with 5 μM HePC-BODIPY
[27] for 45 min at 26 °C in the dark. The fluorescent ana-
log was added directly from an ethanol stock solution.
Parasites were washed with HPMI supplemented with 4%
BSA to remove the non-internalized probe (back-ex-
change), re-suspended in HPMI and maintained on ice.
Cellular fluorescence was measured by flow cytometry
using a Beckman Coulter FC500 Flow Cytometer. Propi-
dium iodide was added to monitor cell viability and
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10,000 events per sample were recorded. Solvent controls
were included and the experiment was performed in
triplicate.
Indirect immunofluorescence
Cells were fixed with 4% paraformaldehyde, perme-
abilized with 0.1% Triton X-100, blocked with 5% BSA,
and incubated with specific anti-lipoic acid antibody
(Abcam, Cambridge, UK) at 1:1,000 dilution. After wash-
ing, the cells were incubated with anti-rabbit Alexa 488
conjugated antibody (1:200 dilution), washed and treated
with DAPI to stain DNA. The slides were mounted with
VectaShield (Vector Laboratories, Burlingame, USA).
Cell fluorescence was captured with a Nikon fluores-
cence microscope equipped with a camera and the
appropriate filters.
Sequence alignment and bioinformatics
DNA sequence data was accessed via http://www.gened-
b.org. Homology searches were carried out using
BLAST with the default BLOSUM-62 substitution
matrix [28]. Multiple sequence alignments of HSP70
homologs were generated with ClustalX (v2.0). Align-
ments were converted to MEGA compatible files and
fed into the MEGA 6.0 software package. A
Neighbor-Joining tree was computed with 500 boot-
strap replicates. The Prosite (http://prosite.expasy.org/)
and Pfam (http://pfam.xfam.org/) databases were used to
identify conserved domains.
Subcellular fractioning and digitonin membrane
permeabilization
For subcellular fractioning, the Qproteome Cell Com-
partment Kit (Qiagen, Valencia, USA) was used follow-
ing the manufacturer’s specifications. Briefly, transgenic
parasites from a logarithmic phase culture were washed,
pelleted and resuspended in 1 ml of lysis buffer. After
10 min incubation at 4 °C, the lysate was centrifuged
and the supernatant (cytosolic fraction) was recovered.
The pellet was resuspended in 1 ml of extraction buffer
CE2 and following a 30 min incubation period, the
supernatant containing membrane proteins and proteins
from the lumen of organelles (e.g. the ER and mitochon-
dria) was recovered. Digitonin membrane permeabilization
was done as previously described [29]. Monitoring of pro-
tein distribution was analyzed by western blot.
Western blot analysis
Crude cell lysates, digitonin enriched and membrane
and lumen organelle enriched fractions were sepa-
rated in 4–12% Bis-Tris NuPAGE gels (Life, Carlsbad,
USA) and revealed using the following antibodies: anti-
GFP-horseradish-peroxidase (HRP)-conjugated antibody
(Miltenyi, Bergisch Gladbach, Germany), rabbit polyclonal
anti-mCherry antibody (Abcam, Cambridge, UK), mouse
monoclonal anti-A2 antibody (Abcam, Cambridge, UK),
mouse monoclonal anti-tubulin antibody (Sigma-Aldrich,
St. Louis, USA), rabbit polyclonal anti-lipoic acid antibody
(Abcam, Cambridge, UK) and anti-rabbit or anti-mouse
HRP-conjugated secondary antibodies (Pierce, Waltham,
USA). After washing, blots were developed using the
SuperSignal chemiluminescent detection system (Pierce,
Waltham, USA).
Sample preparation and labeling for 2D- DIGE
Subcellular fractioned extracts as well as whole protein
extracts from logarithmic cultures of L. donovani WT,
LdR10.1, LdR30.1 and HSPA9B-mCherry promastigotes
were precipitated using a 2-D Clean-Up kit (GE Health-
care, Chicago, USA), allowing for quantitative precipita-
tion and removal of interfering substances such as
detergents, salts, lipids, phenolics, and nucleic acid.
Proteins were then differentially labelled with spectrally
resolvable Cy3 and Cy5 as previously described [30]. A
pool of extracts was labelled with Cy2 for normalization
purposes, following the manufacturer’s recommenda-
tions (GE Healthcare, Chicago, USA).
Isoelectric focusing (IEF) and two-dimensional gel
electrophoresis (2D)
IEF of 275 μg of protein was carried out using an
EttanIPGphor 3 System (GE Healthcare, Chicago, USA) at
20 °C with 13 cm non-linear DryStrip (pH 4–7). Strips
were passively rehydrated overnight at room temperature
in rehydration solution (GE Healthcare, Chicago, USA)
containing 0.5% IPG buffer 4–7 and 2% DTT. The IEF
maximum current setting was 50 mA/strip. The following
conditions were programmed for IEF: 100 V gradient step
for 5 h, 300 V gradient step for 5 h, 1,000 V gradient step
for 2 h, 6,000 V gradient step for 8 h and 6,000 V for 5 h
(60,550 Vh). Following IEF, strips were equilibrated in two
different solutions (6 M urea, 75 mM Tris/HCl pH 8.8,
29.3% glycerol, 4% SDS, and 0.002% bromophenol blue)
supplemented with 65 mM DTT or 13.5 mM iodoaceta-
mide for 15 min each. The strips were transferred to SDS
polyacrylamide gels and sealed with 0.5% agarose in
25 mM Tris-base, 0.19 M glycine, 0.2% SDS and 0.01%
bromophenol blue. Electrophoresis was carried out in an
SE 600 Ruby cooled electrophoresis system (GE Health-
care, Chicago, USA) using 12.5% SDS-PAGE gels and a
two-step run (1 W/gel for 15 min and 7 W/gel for 5 h).
Staining procedures and image analysis
After electrophoresis, gels were scanned on a Typhoon
FLA 9500 Imager (GE Healthcare, Chicago, USA) using
488/520 nm for Cy2, 532/580 nm for Cy3, 633/670 nm
for Cy5 and 100 mm as pixel size. Gel images were nor-
malized by adjusting PMT voltage to obtain appropriate
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pixel value without any saturation. Images were analyzed
with Delta2D v.4.5 software (Decodon). Gels were
matched and warped and spots detected across all
images. A 2-fold difference in abundance, with P-values
< 0.05, was considered significant for the expression
profiles. Polyacrylamide gels were then fixed in 50%
methanol and 7% acetic acid and stained using SYPRO
Ruby total protein gel stain (Life, Carlsbad, USA). Spots
of interest were manually excised from gels visualized on
a blue-light transilluminator (Life, Carlsbad, USA).
Protein identification
Gel spots were subjected to reduction with 55 mM DTT
in 25 mM ammonium bicarbonate (ThermoFisher
Scientific, Waltham, USA) at 56 °C for 1 h followed by
alkylation with 100 mM iodoacetamide (Sigma-Aldrich,
St. Louis, USA) in 25 mM ammonium bicarbonate at
room temperature in the dark for 45 min. The spots
were washed with 25 mM ammonium bicarbonate for
10 min followed by two consecutive washes with 25 mM
ammonium bicarbonate in 50/50 acetonitrile: water for
5 min, each. The spots were placed in a vacuum concen-
trator to dry completely before the addition of 12.5 ng
trypsin gold (Promega, Fitchburg, USA) to each gel spot.
The spots were kept at 4 °C for 30 min to swell and then
were incubated at 37 °C overnight. Following trypsin
digestion, the supernatant was collected. Peptides were
further extracted from the gel spots with two consecu-
tive additions of 50% acetonitrile/ 45% water/ 5%formic
acid followed by 30 min of vortexing. The two sets of
extracts were combined with the supernatant from each
gel spot and then vacuum concentrated to 10 ml. Each
concentrated digest was desalted with a C18 Ziptip
(EMD Millipore, Darmstadt, Germany) according to the
manufacturer instructions. The desalted digests were
then dried down in a vacuum concentrator and reconsti-
tuted in 10 ml of 0.1% TFA in water. A 2 ml aliquot of
each gel digest was injected onto a nanoAcquity UPLC
(Waters Corporation, Milford, USA) with a BEH300 C18
100 mm6100 mm column (Waters Corporation, Milford,
USA) with 1.7 mm particle size. A gradient of 0.1%
formic acid in water (A) and 0.1% formic acid in aceto-
nitrile (B) was performed starting with 2% B held for
6 min and then ramping to 40% B to 40 min and 90% B
to 43 min. The column was washed with 90% B for
7 min and then re-equilibrated with 98% A: 2% B. The
nanoAcquity was coupled to a LTQ Orbitrap Velos mass
spectrometer (Thermo-Fisher Scientific, Waltham, USA)
for data dependent scans of the digested samples in
which the top nine abundant ions in a scan were
selected for CID fragmentation. The UPLC-MS/MS
chromatograms and spectra were analyzed using Xcali-
bur software (Thermo-Fisher Scientific, Waltham, USA),
and the extracted data were searched against the L.
infantum custom database via Mascot and/or Protein
Pilot. Search criteria included a global modification of
carbamidomethylation on the cysteines. Proteins identi-
fied had less than a 1% false discovery rate.
Parasite stress response and reactive oxygen species
(ROS) production
HSPA9B overexpressing promastigotes and their re-
spective mock controls were exposed to different stress
conditions: low pH (pH = 5.5), heat-shock (37 °C), heat-
shock (37 °C) plus low pH (pH = 5.5), starvation and
HePC treatment during 4 and 18 h. Exposure of phos-
phatidylserine (PS) residues was investigated with
Annexin-V-FITC or Annexin-V-Alexa 594 following the
manufacturer’s instructions. Propidium Iodide (Invitro-
gen, Waltham, USA) was added and the cells were incu-
bated for 20 min. Analyses were performed in a
Beckman Coulter FC500 Flow Cytometer. The produc-
tion of intracellular ROS under the conditions described
above was measured using MitoSOX Red (Molecular
Probes, Eugene, USA). The intracellular fluorescence
was measured by flow cytometry.
Statistics
Significance was determined by P-values calculated from
a two-tailed Student’s t-test in GraphPad Prism 7.0 un-
less otherwise stated.
Results
Identification of HSPA9B and in silico analysis
In order to identify molecules potentially implicated in
HePC resistance, we performed comparative 2D-DIGE
of proteins isolated from cultures of L. donovani wild
type (WT) vs LdR10 (“low” level of resistance) promasti-
gotes and L. donovani WT vs LdR30 (“high” level of re-
sistance) promastigotes. Whole extracts were obtained,
differentially labeled with CyDye fluors as detailed in
Methods and separated by 2DE on pH 4–7 IPG immobi-
line strips and SDS-PAGE. Images were analyzed with
Delta2D (Decodon) software. Several proteins were up-
or downregulated more than 2-fold with P-values < 0.05
(data not shown). Interestingly, Spot ID 7 and Spot ID 5
(Fig. 1a) were underrepresented in both LdR10 and
LdR30 (0.381- and 0.468-fold change, respectively,
Fig. 1b) and excised to be further identified by MS/MS
(Fig. 1c). A representative 2D-DIGE gel image is shown
in Additional file 1: Figure S1. The principal components
analysis applied on the gels is indicative of the reprodu-
cibility between replicates (Additional file 2: Figure S2).
Both spots were identified as LinJ30.2480 (Tritryp gene
ID). This gene is a putative heat-shock 70-related protein
1 (mitochondrial precursor) with a predicted MW of
71.6 kDa (designated as HSPA9B [10]).
Vacchina et al. Parasites & Vectors  (2016) 9:621 Page 5 of 15
An in silico analysis of L. infantum database revealed,
in total, the existence of four genes, organized in tan-
dem, encoding for HSPA9A-D. Together, they share
more than 91% identity (Fig. 2). While the N-terminal
segment is conserved, it is the C-terminal end that
shows higher divergence. HSPA9B is highly conserved
among other Leishmania species and related trypanoso-
matids (T. cruzi and T. brucei) with identities above
90%. Additionally, HSPA9B shares a 55–60% identity
with higher eukaryotes (Fig. 2 and Additional file 3:
Figure S3).
To gain a first insight in how HSPA9B expression is
associated to HePC resistance we established trans-
genic parasites overexpressing HSPA9B. This gain-of-
function approach allowed us to overcome current
limitations ssociated with knock out and knock down
strategies, especially because HSPA9B is not a single
copy gene.
Phenotypic characterization of HSPA9B overexpressing
parasites
We followed a gain-of-function approach in order to re-
veal the influence of HSPA9B in the parasite biology. C-
terminal HSPA9B-mCherry (integrative) and N-terminal
GFP-HSPA9B (episomal) fusions were generated and
protein overexpression was confirmed by western blot
and flow cytometry (Fig. 3a, b). Growth curves of the
transgenic lines HSPA9B-mCherry, GFP- HSPA9B and
their respective controls show that overexpression of
HSPA9B does not affect the parasite’s ability to replicate
(Additional file 4: Figure S4).
HSPA9B overexpressing parasites are more sensitive to
drug treatment
We investigated the effects of HSPA9B overexpression
on parasite response to HePC treatment. The assess-
ment of HePC resistance was measured using the
resazurin-based CellTiter-Blue assay described in
Methods. Both overexpressing lines generated in this
study are more sensitive to HePC treatment, regardless
of whether the expression is ectopic or integrative
(Table 1). Because we found HSPA9B to be downregu-
lated (Fig. 1) in resistant LdR10 and LdR30 cell lines
(Table 1), it seems counterintuitive that the overexpres-
sion of HSPA9B confers increased susceptibility to
HePC. The HSP70 protein family is structurally charac-
terized by the presence of three conserved domains: at
the N-terminus there is a highly conserved 44 kDa ATP-
binding/ATPase domain followed by a 13 kDa peptide
binding domain containing two antiparallel beta-sheets.
At the C-terminal end there is an alpha-helical domain
of c.10 kDa whose sequence is less conserved between
distantly related organisms (Fig. 2). To ascertain the
potential and specific role of HSPA9B in HePC resist-
ance, we decided to test the effect of dominant-negative
mutants on drug susceptibility. The constructs HSPA9B-
mCherry (G220D, G221D, denoted as single mutations)
and HSPA9B-mCherry (G220D, G221D, F436V, denoted
Fig. 1 2D-DIGE quantitative analysis of miltefosine-resistant L. donovani. a Enlarged regions of the 2D-DIGE gels showing Cy3-labeled LdR10 or
LdR30 promastigotes and Cy5-labeled WT promastigotes. b Spots ID 7 and 5 were underrepresented in LdR10 and LdR30 lines, respectively, and
expression profiles with significant statistics is shown along with representative 3D regions of the gels. c Spots ID 7 and 5 were excised and later
identified by mass spectrometry as LinJ30.2480 (HSPA9B). The table shows Fold Change (FC) of LdR/LdWT ratio, and Mascot and P-values for spots
ID7 and ID5
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as double mutations) were designed based on previous
studies where the relevance of specific amino acids in
the ATP-binding domain and peptide binding domain
were assessed [15–18]. Following transfection, we mea-
sured HePC sensitivity in transgenic lines (HSPA9B-
mCherry) carrying single (SM) or double mutations
(DM) (Table 1), as described above. The EC50 values of
lines carrying these mutations suggest that the expres-
sion of mutant polypeptides in a WT background signifi-
cantly alters HSPA9B activity. Furthermore, both single
and double mutations are able to revert the HePC-
sensitive phenotype of HSPA9B-mCherry transgenic par-
asites to WT values (Table 1). Overall these data suggest
a specific and important role of HSPA9B in HePC
resistance.
Although L. donovani HePC-resistant lines (LdR30)
did not show cross-resistance against the reference com-
pounds paromomycin, amphotericin B, antimony (III)
and pentamidine isethionate [9], we decided to investi-
gate the possibility of any conferred resistance to the
alternative antileishmanial treatments by measuring
EC50 values in HSPA9B-mCherry overexpressing lines.
Unexpectedly, we found that these cells are significantly
more resistant to amphotericin B, antimony (III) and
pentamidine isethionate when compared to the WT con-
trol (Additional file 5: Table S1). Further studies will be
necessary to understand the role of HSPA9B in resist-
ance to these drugs.
Intracellular accumulation of HePC in transgenic parasites
Previous reports [6, 7, 9, 31–36] have linked reduced
HePC sensitivity to impaired drug incorporation or in-
creased drug extrusion. To assess the ability of HSPA9B
overexpressing transgenic parasites to accumulate HePC,
we monitored the uptake of HePC-BODIPY by flow
cytometry. Under our experimental conditions, we do
not detect significant differences in drug accumulation,
as judged by the similar fluorescence levels (histograms)
of transgenic HSPA9B cultures and their respective con-
trols (Fig. 4). These data suggest that the augmented
HePC susceptibility we observe in the HSPA9B overex-
pressing cultures is not likely caused by an increased
uptake of the HePC fluorescent analog.
Fig. 2 Multiple alignment of L. donovani HSPA9B with other species. The amino acid sequence of Leishmania infantum (Acc. No. XP 001467093)
was aligned with homologs from Leishmania major (Acc. Nos. XP 001684851.1 and XP 001684854.1), Leishmania infantum (Acc. Nos. XP
001467099, XP 001467094.1 and XP 001467098), Trypanosoma brucei (Acc. No. XP 845492.1), Trypanosoma cruzi (Acc. No. XP 806221.1), Mus
musculus (Acc. No. NP 034611.2), Homo sapiens (Acc. No. NP 004125.3) and Saccharomyces cerevisiae (Acc. No. AJV 42692.1) using Clustal X (v2.1)
and edited with Jalview [41]. Conserved (>75%) residues are highlighted and conservation histograms are indicated below each residue
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Subcellular localization of HSPA9B
To ascertain the subcellular localization of HSPA9B, we
performed immunofluorescence microscopy of L. dono-
vani HSPA9B-mCherry promastigotes (Fig. 5a). The
fluorescence pattern of HSPA9B mimics traditional
mitochondrial localization as evidenced by the yellowish
fluorescence, which corresponds to co-localization with
the polyclonal anti-lipoic acid. This antibody recognizes
lipoic acid and lipoic acid covalently attached to proteins
via a lipoamide bond, a cofactor associated to E2
subunits of mitochondrial protein complexes like
pyruvate-dehydrogenase, alpha-ketoglutarate dehydro-
genase and the branched-chain alpha-keto acid. Add-
itional evidence of HSPA9B mitochondrial localization
was obtained from subcellular fractioning of Leishmania
cultures using increasing digitonin concentrations,
allowing progressive membrane permeabilization. At low
digitonin concentrations, only the plasma membrane be-
comes permeable, however higher concentrations are
able to sequentially extract organelle components. The
Fig. 3 Overexpression of HSPA9B-tagged proteins in L. donovani promastigotes. Protein expression in transgenic promastigotes carrying the
episomal construction GFP-HSPA9B-pXG (a) or the integrative version HSPA9B-mCherry (b) were analyzed by flow cytometry and western blot.
Histograms indicate fluorescence intensity of controls (black line) and transfected parasites (green or red filled). Total (CE) and immunopurified
(IP) protein extracts (c) or just total (d) extracts obtained from logarithmic cultures were resolved by SDS-PAGE and probed with anti-GFP or
anti-mCherry antibodies. Blots were stripped and re-probed with an anti-α-tubulin antibody as a loading control. Molecular weights are indicated
in kDa
Table 1 Miltefosine susceptibility of L. donovani populations determined by EC50 assays. Upon analysis, parasite lines show
increasing degrees of resistance to HePC as selection pressure increases (denoted as LdR10 and LdR30, respectively). Transgenic lines
over-expressing HSPA9B show increased sensitivity to drug treatment as compared to their controls. Sensitivity reverts back to WT
like values upon generating mutations in the ATP binding domain (GxD, GxD, referred to as SM) or both the ATP and peptide bind-
ing domains (GxD, GxD, FxV, referred to as DM)
EC50 (mean ± SD for at least 3 replicates)
HePC resistant linesa Transgenic lines HSPA9B-mCherry mutants
LdR10 LdR30 pXG GFP-HSPA9B WT HSPA9B-mCherry SM DM
HePC 38.99 ± 5.06 94.04 ± 16.82 8.14 ± 0.45 5.76 ± 0.53 7.04 ± 0.36 3.92 ± 0.23 6.7 ± 0.27 6.95 ± 0.61
aThese EC50 values were previously determined and published by our group [9]
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selective permeabilization was carried out according to
the Foucher et al. fractioning method [29]. According to
this protocol, cytosolic proteins are mainly found in frac-
tions 1 and 2, mitochondrial proteins are mostly recov-
ered in fractions 3 and 4 while fraction 5 is mainly
enriched in cytoskeleton and cytoskeleton-associated
proteins. Fractions were separated by SDS-PAGE, under-
went western blotting and were further incubated with
anti-mCherry and anti-lipoic acid antibodies. The
98 kDa HSPA9B-mCherry fusion protein, recognized by
the mCherry antibody, is detected in fractions 4 and 5.
A similar result is obtained with anti-lipoic acid (Fig. 5b).
Together, our results confirm the mitochondrial
localization of HSPA9B.
Effect of environmental stress on transgenic HSPA9B
parasites
Leishmania spp. are digenetic pathogens where
temperature shift takes place as part of their life-cycle.
Phases of low temperatures in the insect vector and
higher temperatures in the mammalian host are ac-
companied by a strong induction of heat-shock pro-
teins [14, 37]. Increased expression of HSPs protect
the cell by stabilizing unfolded proteins, giving the
cell time to repair or re-synthesize damaged proteins
during heat-shock transitions.
We analyzed transgenic L. donovani promastigotes
overexpressing HSPA9B, both integrated or episomally,
in order to investigate how HSPA9B may affect the
Fig. 4 Miltefosine incorporation in transgenic L. donovani parasites. Cells were incubated with 5 μM MIL-BODIPY and subsequently washed with
4% BSA in HPMI buffer (w/v) and analyzed by flow cytometry. a MIL-BODIPY uptake in GFP-HSPA9B-pXG (green filled line) and mock parasites
(black line). b MIL-BODIPY accumulation in HSPA9B-mCherry (red filled line) and WT parasites (black line). Culture auto-fluorescence is indicated as
dotted lines. These are representative histograms of at least three independent experiments
Fig. 5 Subcellular localization of HSPA9B. a Immunofluorescence microscopy of HSPA9B-mCherry promastigotes (red) using a primary polyclonal
antibody against lipoic acid and a FITC-conjugated anti-rabbit (green) as a secondary antibody. DNA was stained with NucBlue fixed cell stain
(DAPI, blue). Scale-bar: 5 μm. Images were obtained with a Nikon 90/NikonAZ 100 microscope. b Western blot of subcellular fractions obtained by
digitonin fractioning of HSPA9B-mCherry parasites. Samples were separated by SDS-PAGE, transferred on to a PVDF membrane and assayed with
anti-mCherry antibody. The membrane was stripped and re-probed with a polyclonal anti-lipoamide antibody. Molecular weights are indicated in
kDa. Fractions (F) 1 and 2 contain cytosolic proteins, mitochondrial proteins are mostly recovered in fractions (F) 3 and 4; fraction (F) 5 is enriched
in cytoskeleton and cytoskeleton-associated proteins
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ability of cells to cope with stressful environments.
Parasites were exposed to different stress conditions:
low pH (pH = 5.5), heat-shock (37 °C), heat-hock (37 °C)
plus low pH (pH = 5.5), starvation and HePC treatment
during 4 and 18 h. Cell health was monitored by measur-
ing early (PS exposure) and late (PI permeability) apop-
totic indicators. Analyses were performed in a Beckman
Coulter FC500 Flow Cytometer and FSC vs SSC plots
were used for gating cells and for identifying changes in
the scatter properties of the cells. After 4 h, both exposed
and non-exposed cultures are viable and non-apoptotic.
Substantial changes are only detected after 18 h of treat-
ment (Fig. 6a). For all lines analyzed, low pH, high
temperature and a combination of both significantly
increase the number of stressed cells, evidenced by the
augmented percentage of early and late apoptotic parasites
when compared to normal growth conditions (27 °C, pH
= 7.2) (Fig. 6a). Interestingly, transgenic HSPA9B parasites
elicit a moderate stress response, with c.40% of cells posi-
tive for PS and c.50% positive for PI (Fig. 6a). Conversely,
control lines display c.60% and 80% positive cells for PS
and PI, respectively, suggesting that HSPA9B overexpres-
sion is able to protect cells from taxing environmental
changes.
Mitochondria superoxide accumulation was also tested
in the same conditions previously described. Superoxide
anion levels were followed with MitoSox in a Beckman
Coulter FC500 Flow Cytometer. While pH media reduc-
tion alone does not modify the radical production of
superoxide in transgenic lines when compared to con-
trols, temperature shift along with low pH or incubation
with 40 μM HePC increases significantly superoxide
accumulation in overexpressing cultures (Fig. 6b),
suggesting that these parasites are more susceptible to
oxidative stress damage. To further study this possibility
we performed comparative proteomics experiments of
mitochondrial protein enriched extracts.
2D-DIGE of membrane-associated proteins from HSPA9B
transgenic lines
Protein extracts enriched in mitochondrial membrane and
lumen components were obtained by fractionation with
the Qproteome Cell Compartment Kit. After labelling, ex-
tracts from WT and HSPA9B-mCherry transgenic lines
were subjected to 2D-DIGE analysis as described in
Methods (Fig. 7a). Spot ID 1 (0.461-fold change; P =
0.019) and Spot ID 3 (2.839-fold change; P = 0.0032)
(Fig. 7b) were identified as a S-adenosylmethionine
Fig. 6 Environmentally-induced stress response and ROS generation in L. donovani overexpressing HSPA9B. a Promastigotes were exposed to low
pH (pH = 5.5), heat-shock (37 °C), heat-shock (37 °C) plus low pH (pH = 5.5), starvation and HePC treatment. Control cells were incubated at 27 °C.
The percentage (%) of early apoptotic-AnnexinV positive cells and late apoptotic-PI positive cells was measured by flow cytometry. These
are representative histogram bars of at least two independent experiments. b Production of intracellular ROS under low pH (pH = 5.5),
heat-shock (37 °C) plus low pH (pH = 5.5) and HePC treatment was measured by flow cytometry using MitoSOX Red. Data are the means ± standard
deviations (SD) of three independent experiments. *P < 0.05
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synthetase –S-AdoMetS- (LinJ.30.3560) and peroxire-
doxin –mTXPNx- (LinJ.23.0050), respectively (Fig. 7c).
The principal components analysis applied on the gels is
indicative of the reproducibility between replicates (Add-
itional file 6: Figure S5). These two enzymes have been im-
plicated in redox metabolism in trypanosomatids [38–40].
Specifically, S-AdoMetS is responsible for adenosyl-
methionine synthesis, a key compound in the trypa-
nothione biosynthetic pathway [38], and has been recently
linked to methotrexate resistance [39, 41]. mTXPNx, how-
ever, is a mitochondrial protein and its expression has
been associated, in L. donovani, with reduced susceptibil-
ity to programed cell death (PCD) [40].
Phenotypic characterization of axenic amastigotes
overexpressing HSPA9B
Our results suggest that HSPA9B overexpression pro-
tects parasites against changes in stressful environmental
conditions such as low pH and high temperature.
Because Leishmania parasites face similar environmental
conditions upon infection of host cells and differenti-
ation into amastigotes we sought to determine the
effects of HSPA9B overexpression on differentiation into
axenic amastigotes and further, on proliferation. L. dono-
vani transgenic (HSPA9B-mCherry) and WT promasti-
gotes from a late-log culture were inoculated in low pH
medium and subjected to 37 °C and 5% CO2 incubation
Fig. 7 2D-DIGE quantitative analysis of the membrane-associated proteome of HSPA9B-mCherry transgenic L. donovani. a Protein extracts were
enriched for mitochondrial membrane and lumen components using the Qproteome Cell Compartment Kit. A representative gel image is shown.
b Spots ID 1 and 3 are under- and overrepresented, respectively, in the HSPA9B-mCherry line and expression profiles with significant statistics is
shown along with representative 3D regions of the gels. c After image analysis, spots were excised and identified by mass spectrometry. The table
shows the Fold Change (FC) HSPA9B-mCherry/WT ratio, as well as Mascot and P-values for spots ID1 and ID3
Fig. 8 Effect of HSPA9B overexpression on differentiation. a L. donovani WT and transgenic promastigotes (HSPA9B-mCherry) were inoculated in
low pH (pH = 5.5) medium and 37 °C to trigger differentiation to axenic amastigotes. Cells were collected 24 and 48 h post-induction of differentiation
and either lysed for western blotting with axenic amastigote A2 marker and anti-tubulin as a loading control or counted using a Neubauer chamber.
b The molecular weight of standard proteins is indicated in kDa and the mean ± standard deviation (SD) of triplicate determinations are
shown, respectively
Vacchina et al. Parasites & Vectors  (2016) 9:621 Page 11 of 15
to trigger differentiation into axenic amastigote. Cells
were lysed 24 and 48 h post-differentiation, and a west-
ern blot was performed with axenic amastigote marker
A2 and anti-tubulin as a loading control (Fig. 8a). Add-
itionally, the number of fully differentiated cells was
determined at each time point (Fig. 8b). Both WT and
HSPA9B-mCherry cell lines are able to fully differentiate
into axenic amastigotes within 48 h, as judged by the ex-
pression of A2. It is important to note that the transgenic
line displays a higher number of amastigotes, suggesting
once again that the overexpression of HSPA9B may confer
Leishmania an advantage to cope with the harsh environ-
ment encountered during differentiation.
Discussion
We have previously applied next-generation sequencing
(NGS) technologies to better comprehend the mecha-
nisms of HePC resistance in L. donovani [9]. Even
though observations of clinical resistance to HePC are
scarce, its long half-life (approximately 120 h) and low
therapeutic window make the emergence of resistance
on a larger scale a very likely process. Until fully charac-
terized resistant field isolates become available, experi-
mental selection of HePC resistance in the laboratory
may offer insight into potential mechanisms of resist-
ance and contribute to design strategies to prevent
emergence and spread of resistance.
An interesting feature of the Leishmania (and other
trypanosomatids) genome is the unusual nature of tran-
scription and RNA processing. Protein coding genes are
organized into long gene clusters [42, 43], and the
resulting polycistronic RNAs are post-transcriptionally
processed into mature mRNAs by concomitant trans-
splicing and polyadenylation. In addition, trypanosoma-
tids appear to have few of the regulatory transcription
factors found in higher eukaryotes [43] and transcrip-
tion initiates at fewer than 200 sites in the entire gen-
ome [44, 45]. Thus, these organisms largely lack the
transcriptional regulation of gene expression charac-
teristic of other eukaryotes [45] and, as a conse-
quence, proteomic studies often render a more useful
view of the biology of the parasite. We performed
quantitative in-gel proteomics comparing control WT and
HePC-resistant LdR10.1 and LdR30.1 L. donovani pro-
mastigotes (Fig. 1) and identified HSPA9B, a mitochon-
drial HSP70, downregulated in both resistant lines.
Proteins of the HSP70 family are central components
of many fundamental cellular processes, including the
folding and assembly of newly synthesized proteins and
refolding of misfolded and aggregated proteins. Mem-
bers of the HSP70 family localized in the mitochondria,
such as HSPA9B, are most similar to the bacterial DnaK
[13]. Moreover, in most organisms, ER and mitochon-
drial HSP70s are constituted by a sole protein, however
an interrogation of the L. donovani genome revealed
four HSPA9 genes (A-D) with minor sequence differ-
ences suggesting divergent evolution of this protein sub-
family [10]. A previous report from 2008 demonstrated
the existence of two distinct HSPA9B homologs in L.
chagasi fortuitously isolated from an immunoscreening
of a L. chagasi cDNA expression library [14] showing
the same sequence arrangement.
Besides their role in thermotolerance, it has been shown
that HSPs also play a role in resistance to some antileish-
manial compounds, particularly antimonials. For instance,
cosmids recovered from SbIII resistant promastigotes con-
tained two copies of cytoplasmic HSP70 and one copy of
HSC70 [46]. Moreover, the expression of HSP70 was aug-
mented when cells were grown at 2× the SbIII EC50,
suggesting a link of HSP70 to antimony response and re-
sistance. It was also observed that transfection of HSP70
does not confer resistance to SbIII directly.
We seemingly uncovered a link between HePC resist-
ance and HSPA9B expression in our 2D-DIGE experiment
and generated an overexpression system to further cor-
roborate this connection. Our gain-of-function approach
demonstrates that transgenic lines overexpressing
HSPA9B are more susceptibility to HePC (Table 1). This
phenotype is independent of the method employed, i.e. in-
tegrative (HSPA9B-mCherry) or episomal (GFP-HSPA9B).
Furthermore, our data suggest that the increased sensitiv-
ity to HePC is specific to HSPA9B overexpression since
dominant negative mutant lines (HSPA9B -mCherry
(GxD, GxD) and HSPA9B -mCherry (GxD, GxD, FxV))
are able to restore HePC susceptibility to WT values
(Table 1), emphasizing the importance of the ATP-binding
and peptide binding domains for the proper function of
HSPA9B. HePC internalization remains the main deter-
minant of drug susceptibility and it correlates with the
levels of the HePC translocation complex [36]. Remark-
ably, we found that the augmented susceptibility of
HSPA9B transgenic lines to HePC does not correlate with
an increased HePC uptake (Fig. 4). Although we did not
measure directly the expression levels of LdMT and
LdRos3, our data indirectly suggest that HePC is internal-
ized at a similar rate based on the accumulation of the
HePC fluorescent analog, underscoring the multi-factorial
mechanism of HePC resistance in Leishmania spp.
As mentioned above, HSPs have been previously
implicated in drug resistance with the analysis of
antimony-resistant clinical isolates of L. donovani. In
one analysis, both cytoplasmic and mitochondrial forms
of HSP70 were upregulated (up to 5-fold) in resistant
isolates [47]. Authors concluded that the most plausible
explanation is that HSP70 may protect Leishmania from
drug-induced programmed cell death (PCD). Antimo-
nials kill cells via a process reminiscent of PCD, and thus
HSP70 may have an anti-apoptotic effect. A similar
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mechanism has been proposed for HePC, in which cells
are killed by a process leading to PCD, including cell
shrinkage, DNA fragmentation and changes in mem-
brane composition. The downregulation of HSPA9B in
HePC-resistant L. donovani may have an indirect anti-
apoptotic effect and we speculate that HSP9C cooperates
closely with other chaperones in the matrix compart-
ment, e.g. HSP60, altering the network of mitochondrial
chaperones and ultimately protecting mitochondrial pro-
teins from misfolding due to HePC stress.
In order to better understand the role of HSPA9B in
the biology of the parasite we subjected L. donovani pro-
mastigotes overexpressing HSPA9B to different stressful
environments. After 18 h of treatment (a combination of
low pH and high temperature) transgenic lines display a
lower percentage of early (PS exposure) and late (PI)
apoptotic cells (Fig. 6a) suggesting that HSPA9B is cap-
able of protecting cells from stressful environmental
conditions. This phenotype was further corroborated in
axenic amastigotes transfected with an episomal copy of
HSPA9B. These transgenic amastigotes differentiate and
proliferate faster than control cells (Fig. 8) confirming
the potential protective role of HSPA9B upon environ-
mental stress. These data highlight a fascinating func-
tional dichotomy for HSPA9B: its downregulation in
HePC resistant lines may protect cells from drug-
induced PCD, however its overexpression, unexpectedly,
does not increase the sensitivity of Leishmania to envir-
onmental stress and, on the contrary, we observe a
protective role under low pH and high temperature.
Several studies have pinpointed mitochondrial-
dependent apoptosis and generation of ROS as major ef-
fectors in the mechanism of action of HePC [48, 49].
We measured superoxide accumulation with the fluores-
cent dye MitoSox (indicative of ROS levels in the mito-
chondria) under low pH and high temperature, and
showed that transgenic parasites overexpressing
HSPA9B are more susceptible to oxidative stress damage
(Fig. 6b). This result may support one of the potential
functions of HSPA9B: the underexpression of HSPA9B
in the HePC resistant lines generated in our laboratory
partially protects the cells against drug-induced oxida-
tive stress. Furthermore, it is well known that L. dono-
vani promastigotes resistant to HePC usually exhibit
different metabolic adaptations leading to protection
against oxidative stress [49]. In this regard we performed
2D-DIGE analysis of enriched mitochondrial proteins
from HSPA9B overexpressing promastigotes and control
cells (Fig. 7). S-adenosylmethionine syntethase is down-
regulated (0.461-fold change) in transgenic lines and
from this we may infer that the levels of its substrate,
AdoMet, part of the trans-sulfuration pathway, may also
be affected. Changes in AdoMet production have been
identified in drug resistant Leishmania and a correlation
with oxidative stress has been established [49]. The sec-
ond protein identified in our comparative proteomics
analysis (Fig. 7) is a mitochondrial peroxiredoxin,
mTXNPx, upregulated in transgenic lines. Remarkably,
Teixeira et al. have shown that mTXNPx functions as a
temperature-sensitive cochaperone in L. infantum [50].
In this study it was demonstrated that mTXNPx prevents
protein aggregation in Leishmania promastigotes under
temperature of 37 °C. Briefly, the change in temperature
activates the chaperone function of mTXNPx causing it to
bind to client unfolded proteins to prevent them from
forming cytotoxic aggregates. These client proteins can
then be reactivated by members of the HSP70 system. We
hypothesize that HSP9AC overexpression leads to an
overexpression of mTXNPx and as a result cells are more
protected from environmental stress that includes changes
in temperature and pH. It would be interesting in future
studies to reveal the potential interaction of HSPA9B and
mTXNPx, along with other members of the mitochondrial
chaperone network.
Conclusions
Experimental resistance to HePC is not yet fully under-
stood. We have used in this study quantitative in-gel
proteomics to compare HePC-resistant and sensitive L.
donovani lines previously generated and have identified
a mitochondrial HSPA9B. The role of HSPA9B in HePC
resistance is evidenced by a gain-of-function approach
and mutagenesis analysis. Interestingly, we have also re-
vealed some of the fundamental roles of HSPA9B in the
biology of Leishmania such as its implication in environ-
mental and oxidative stress. Overall, our findings are
relevant for current and future antileishmanial chemo-
therapy strategies.
Additional files
Additional file 1: Figure S1. Representative 2D-DIGE images of LdWT
vs LdR10 (left panel) and LdWT vs LdR30 (right panel). Samples were
differentially labeled with fluorescent CyDyes, separated on a 2D-DIGE
gel using 13 cm pH 4–7 strips in the first dimension and 12% SDS PAGE
gels in the second dimension, and revealed with a Typhoon fluorescent
scanner. (PDF 985 kb)
Additional file 2: Figure S2. Principal components analysis (PCA) of
LdWT vs LdR10/LdR30 2D-DIGE. Statistical analysis shows the “good”
clustering of the biological replicates for each experiment: (a) WT vs
LdR10 and (b) WT vs LdR30). (PDF 64 kb)
Additional file 3: Figure S3. Bioinformatic analysis of L. infantum
(LinJ.30.2480). The relationship of L. infantum HSPA9B to other HSPA9B
homologs of L. infantum, L. major, T. brucei, T. cruzi, S. cerevisiae, M.
musculus and H. sapiens was analyzed by multiple alignment and
cluster analysis using Clustal X. Alignment was fed into MEGA 6.0
software and a Neighbor-Joining tree was computed with 500 bootstrap
replicates. Numbers on the notes indicate bootstrap support. (PDF 10 kb)
Additional file 4: Figure S4. Growth curves of L. donovani transgenic
lines. Parasite concentration of (a) GFP-pXG mock and GFP-HSPA9B-pXG
and (b) WT and HSPA9B-mCherry promastigote cultures was measured
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microscopically by counting cells in a Neubauer chamber daily for 5 days.
The mean ± SD of triplicate determinations are shown. (PDF 36 kb)
Additional file 5: Table S1. Cross-resistance to reference compounds.
HSPA9B-mCherry overexpressing lines are significantly more resistant to
amphotericin B, antimony (III) and pentamidine isethionate when compared
to WT cultures. All the cultures were analyzed in triplicate and data is
indicated as mean ± SD of three independent experiments. (PDF 40 kb)
Additional file 6: Figure S5. Principal components analysis (PCA) of WT
vs HSPA9B-mCherry 2D-DIGE. Statistical analysis shows the “good” clustering
of the biological replicates for each sample. (PDF 41 kb)
Abbreviations
2D-DIGE: Two-dimensional fluorescence difference gel electrophoresis;
ATP: Adenosine triphosphate; BODIPY: Boron-dipyrromethene; BSA: Bovine
serum albumin; DAPI: 4′,6-diamidino-2-phenylindole; DTT: Dithiothreitol;
ER: Endoplasmic reticulum; FCS: Fetal calf serum; FSC: Forward scatter;
HePC: Hexadecyl-phosphatidylcholine; HRP: Horseradish peroxidase;
HSP: Heat-shock protein; HYGB: Hygromycin; IPG: Immobilized pH gradient;
MS: Mass spectrometry; MT: Miltefosine transporter; PCD: Programed cell
death; SDS: Sodium dodecyl sulfate; SSC: Side scatter; UV: Ultraviolet;
VL: Visceral leishmaniasis; WT: Wild type
Acknowledgements
We thank Dr. Luis Rivas (CIB, CSIC, Madrid, Spain) for kindly sharing the
fluorescent miltefosine analog.
Funding
This work was supported by the Eck Institute of Global Health and partially
by the Indiana Clinical and Translational Sciences Institute funded, in part
by Grant Number #UL1TR001108 from the National Institutes of Health,
National Centre for Advancing Translational Sciences, Clinical and Translational
Sciences Award. MAM was supported by capitalization funds from the University
of Notre Dame.
Availability of data and materials
The datasets and cell lines supporting the conclusions of this article are
included within the article.
Authors’ contributions
PV and MAM conceived the study and helped draft the manuscript. PV, BMN
and EC carried out the studies, statistical analysis and drafted the manuscript.
MAM wrote the manuscript. All authors read and approved the final version
of the manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
Not applicable.
Received: 26 August 2016 Accepted: 22 November 2016
References
1. Lukes J, Mauricio IL, Schonian G, Dujardin JC, Soteriadou K, Dedet JP, et al.
Evolutionary and geographical history of the Leishmania donovani complex
with a revision of current taxonomy. Proc Natl Acad Sci USA. 2007;104(22):
9375–80.
2. World Health O. Control of the leishmaniases. World Health Organ Tech Rep
Ser. 2010;949:1–186, back cover. PMID:21485694.
3. Zilberstein D, Shapira M. The role of pH and temperature in the
development of Leishmania parasites. Annu Rev Microbiol. 1994;48:449–70.
4. Croft SL, Neal RA, Pendergast W, Chan JH. The activity of alkyl
phosphorylcholines and related derivatives against Leishmania donovani.
Biochem Pharmacol. 1987;36(16):2633–6.
5. Sundar S, Singh A, Rai M, Prajapati VK, Singh AK, Ostyn B, et al. Efficacy of
miltefosine in the treatment of visceral leishmaniasis in India after a decade
of use. Clin Infect Dis. 2012;55(4):543–50.
6. Perez-Victoria FJ, Sanchez-Canete MP, Castanys S, Gamarro F. Phospholipid
translocation and miltefosine potency require both L. donovani miltefosine
transporter and the new protein LdRos3 in Leishmania parasites. J Biol
Chem. 2006;281(33):23766–75.
7. Castanys-Munoz E, Alder-Baerens N, Pomorski T, Gamarro F, Castanys S. A
novel ATP-binding cassette transporter from Leishmania is involved in
transport of phosphatidylcholine analogues and resistance to alkyl-
phospholipids. Mol Microbiol. 2007;64(5):1141–53.
8. BoseDasgupta S, Ganguly A, Roy A, Mukherjee T, Majumder HK. A novel
ATP-binding cassette transporter, ABCG6 is involved in chemoresistance of
Leishmania. Mol Biochem Parasitol. 2008;158(2):176–88.
9. Vacchina P, Norris-Mullins B, Abengozar MA, Viamontes CG, Sarro J,
Stephens MT, et al. Genomic appraisal of the multifactorial basis for in vitro
acquisition of miltefosine resistance in Leishmania donovani. Antimicrob
Agents Chemother. 2016;60(7):4089–100.
10. Drini S, Criscuolo A, Lechat P, Imamura H, Skalicky T, Rachidi N, et al.
Species- and strain-specific adaptation of the HSP70 super family in
pathogenic trypanosomatids. Genome Biol Evol. 2016;8(6):1980–95.
11. Mayer MP, Bukau B. Hsp70 chaperones: cellular functions and molecular
mechanism. Cell Mol Life Sci. 2005;62(6):670–84.
12. Folgueira C, Requena JM. A postgenomic view of the heat shock proteins
in kinetoplastids. FEMS Microbiol Rev. 2007;31(4):359–77.
13. Gupta RS, Golding GB, Singh B. HSP70 phylogeny and the relationship
between archaebacteria, eubacteria, and eukaryotes. J Mol Evol. 1994;39(5):
537–40.
14. Campos RM, Nascimento M, Ferraz JC, Pereira MM, Rocha PO, Thompson
GM, et al. Distinct mitochondrial HSP70 homologues conserved in various
Leishmania species suggest novel biological functions. Mol Biochem
Parasitol. 2008;160(2):157–62.
15. Laufen T, Mayer MP, Beisel C, Klostermeier D, Mogk A, Reinstein J, et al.
Mechanism of regulation of hsp70 chaperones by DnaJ cochaperones. Proc
Natl Acad Sci USA. 1999;96(10):5452–7.
16. McClellan AJ, Brodsky JL. Mutation of the ATP-binding pocket of SSA1
indicates that a functional interaction between Ssa1p and Ydj1p is required
for post-translational translocation into the yeast endoplasmic reticulum.
Genetics. 2000;156(2):501–12.
17. Needham PG, Patel HJ, Chiosis G, Thibodeau PH, Brodsky JL. Mutations in
the yeast Hsp70, Ssa1, at P417 alter ATP cycling, interdomain coupling, and
specific chaperone functions. J Mol Biol. 2015;427(18):2948–65.
18. Bell SL, Chiang AN, Brodsky JL. Expression of a malarial Hsp70 improves
defects in chaperone-dependent activities in ssa1 mutant yeast. PLoS One.
2011;6(5):e20047.
19. Giambiagi-deMarval M, Souto-Padron T, Rondinelli E. Characterization and
cellular distribution of heat-shock proteins HSP70 and HSP60 in
Trypanosoma cruzi. Exp Parasitol. 1996;83(3):335–45.
20. Olson CL, Nadeau KC, Sullivan MA, Winquist AG, Donelson JE, Walsh CT, et
al. Molecular and biochemical comparison of the 70-kDa heat shock
proteins of Trypanosoma cruzi. J Biol Chem. 1994;269(5):3868–74.
21. Klein KG, Olson CL, Donelson JE, Engman DM. Molecular comparison of the
mitochondrial and cytoplasmic hsp70 of Trypanosoma cruzi, Trypanosoma
brucei and Leishmania major. J Eukaryot Microbiol. 1995;42(5):473–6.
22. Searle S, McCrossan MV, Smith DF. Expression of a mitochondrial stress
protein in the protozoan parasite Leishmania major. J Cell Sci. 1993;104(Pt
4):1091–100.
23. MacFarlane J, Blaxter ML, Bishop RP, Miles MA, Kelly JM. Identification and
characterisation of a Leishmania donovani antigen belonging to the 70-kDa
heat-shock protein family. Eur J Biochem. 1990;190(2):377–84.
24. Goyard S, Segawa H, Gordon J, Showalter M, Duncan R, Turco SJ, et al. An
in vitro system for developmental and genetic studies of Leishmania
donovani phosphoglycans. Mol Biochem Parasitol. 2003;130(1):31–42.
25. Ha DS, Schwarz JK, Turco SJ, Beverley SM. Use of the green fluorescent protein
as a marker in transfected Leishmania. Mol Biochem Parasitol. 1996;77(1):57–64.
26. Vacchina P, Morales MA. In vitro screening test using Leishmania
promastigotes stably expressing mCherry protein. Antimicrob Agents
Chemother. 2014;58(3):1825–8.
27. Hornillos V, Carrillo E, Rivas L, Amat-Guerri F, Acuna AU. Synthesis of BODIPY-
labeled alkylphosphocholines with leishmanicidal activity, as fluorescent
analogues of miltefosine. Bioorg Med Chem Lett. 2008;18(24):6336–9.
Vacchina et al. Parasites & Vectors  (2016) 9:621 Page 14 of 15
28. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, et al.
Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs. Nucleic Acids Res. 1997;25(17):3389–402.
29. Foucher AL, Papadopoulou B, Ouellette M. Prefractionation by digitonin
extraction increases representation of the cytosolic and intracellular
proteome of Leishmania infantum. J Proteome Res. 2006;5(7):1741–50.
30. Norris-Mullins B, VanderKolk K, Vacchina P, Joyce MV, Morales MA.
LmaPA2G4, a homolog of human Ebp1, is an essential gene and inhibits
cell proliferation in L. major. PLoS Negl Trop Dis. 2014;8(1):e2646.
31. Parodi-Talice A, Araujo JM, Torres C, Perez-Victoria JM, Gamarro F, Castanys
S. The overexpression of a new ABC transporter in Leishmania is related to
phospholipid trafficking and reduced infectivity. Biochim Biophys Acta.
2003;1612(2):195–207.
32. Perez-Victoria FJ, Castanys S, Gamarro F. Leishmania donovani resistance to
miltefosine involves a defective inward translocation of the drug.
Antimicrob Agents Chemother. 2003;47(8):2397–403.
33. Perez-Victoria FJ, Gamarro F, Ouellette M, Castanys S. Functional cloning
of the miltefosine transporter. A novel P-type phospholipid translocase
from Leishmania involved in drug resistance. J Biol Chem. 2003;278(50):
49965–71.
34. Seifert K, Matu S, Javier Perez-Victoria F, Castanys S, Gamarro F, Croft SL.
Characterisation of Leishmania donovani promastigotes resistant to
hexadecylphosphocholine (miltefosine). Int J Antimicrob Agents. 2003;22(4):
380–7.
35. Castanys-Munoz E, Perez-Victoria JM, Gamarro F, Castanys S.
Characterization of an ABCG-like transporter from the protozoan parasite
Leishmania with a role in drug resistance and transbilayer lipid movement.
Antimicrob Agents Chemother. 2008;52(10):3573–9.
36. Sanchez-Canete MP, Carvalho L, Perez-Victoria FJ, Gamarro F, Castanys S.
Low plasma membrane expression of the miltefosine transport complex
renders Leishmania braziliensis refractory to the drug. Antimicrob Agents
Chemother. 2009;53(4):1305–13.
37. Teixeira PC, Velasquez LG, Lepique AP, de Rezende E, Bonatto JM, Barcinski
MA, et al. Regulation of Leishmania (L.) amazonensis protein expression by
host T cell dependent responses: differential expression of oligopeptidase B,
tryparedoxin peroxidase and HSP70 isoforms in amastigotes isolated from
BALB/c and BALB/c nude mice. PLoS Negl Trop Dis. 2015;9(2):e0003411.
38. Reguera RM, Redondo CM, Perez-Pertejo Y, Balana-Fouce R. S-
Adenosylmethionine in protozoan parasites: functions, synthesis and
regulation. Mol Biochem Parasitol. 2007;152(1):1–10.
39. Drummelsmith J, Girard I, Trudel N, Ouellette M. Differential protein
expression analysis of Leishmania major reveals novel roles for methionine
adenosyltransferase and S-adenosylmethionine in methotrexate resistance. J
Biol Chem. 2004;279(32):33273–80.
40. Harder S, Bente M, Isermann K, Bruchhaus I. Expression of a mitochondrial
peroxiredoxin prevents programmed cell death in Leishmania donovani.
Eukaryot Cell. 2006;5(5):861–70.
41. Guimond C, Trudel N, Brochu C, Marquis N, El Fadili A, Peytavi R, et al.
Modulation of gene expression in Leishmania drug resistant mutants as
determined by targeted DNA microarrays. Nucleic Acids Res. 2003;31(20):
5886–96.
42. Worthey EA, Martinez-Calvillo S, Schnaufer A, Aggarwal G, Cawthra J,
Fazelinia G, et al. Leishmania major chromosome 3 contains two long
convergent polycistronic gene clusters separated by a tRNA gene. Nucleic
Acids Res. 2003;31(14):4201–10.
43. Ivens AC, Peacock CS, Worthey EA, Murphy L, Aggarwal G, Berriman M, et al.
The genome of the kinetoplastid parasite. Leishmania major. Science. 2005;
309(5733):436–42.
44. Thomas S, Green A, Sturm NR, Campbell DA, Myler PJ. Histone acetylations
mark origins of polycistronic transcription in Leishmania major. BMC
Genomics. 2009;10:152.
45. Clayton C, Shapira M. Post-transcriptional regulation of gene expression in
trypanosomes and leishmanias. Mol Biochem Parasitol. 2007;156(2):93–101.
46. Brochu C, Haimeur A, Ouellette M. The heat shock protein HSP70 and heat
shock cognate protein HSC70 contribute to antimony tolerance in the
protozoan parasite leishmania. Cell Stress Chaperones. 2004;9(3):294–303.
47. Biyani N, Singh AK, Mandal S, Chawla B, Madhubala R. Differential
expression of proteins in antimony-susceptible and -resistant isolates of
Leishmania donovani. Mol Biochem Parasitol. 2011;179(2):91–9.
48. Mishra J, Singh S. Miltefosine resistance in Leishmania donovani involves
suppression of oxidative stress-induced programmed cell death. Exp
Parasitol. 2013;135(2):397–406.
49. Berg M, Garcia-Hernandez R, Cuypers B, Vanaerschot M, Manzano JI, Poveda
JA, et al. Experimental resistance to drug combinations in Leishmania
donovani: metabolic and phenotypic adaptations. Antimicrob Agents
Chemother. 2015;59(4):2242–55.
50. Teixeira F, Castro H, Cruz T, Tse E, Koldewey P, Southworth DR, et al.
Mitochondrial peroxiredoxin functions as crucial chaperone reservoir in
Leishmania infantum. Proc Natl Acad Sci USA. 2015;112(7):E616–24.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Vacchina et al. Parasites & Vectors  (2016) 9:621 Page 15 of 15
